BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Down 93.3% in March

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 1,000 shares, a decrease of 93.3% from the February 28th total of 15,000 shares. Based on an average daily trading volume, of 16,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are short sold.

BioNxt Solutions Stock Performance

OTCMKTS BNXTF traded down $0.04 during trading on Thursday, reaching $0.39. 200 shares of the company’s stock were exchanged, compared to its average volume of 10,215. The stock has a market cap of $44.50 million, a P/E ratio of -9.81 and a beta of 0.62. BioNxt Solutions has a 1 year low of $0.11 and a 1 year high of $0.43. The company has a 50 day moving average price of $0.34 and a two-hundred day moving average price of $0.25.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.